Quantcast
Last updated on June 20, 2013 at 7:48 EDT
Laughing Gas Does Not Lead To Heart Attacks According To New

Laughing Gas Does Not Lead To Heart Attacks, According To New Study

Lee Rannals for redOrbit.com - Your Universe Online Researchers at Washington University School of Medicine in St. Louis determined that laughing gas does not increase the risk of a heart attack during surgery. Nitrous oxide, more commonly...

Latest Thiols Stories

2013-05-21 04:20:51

SALT LAKE CITY, May 21, 2013 /PRNewswire/ -- MAX International, L.L.C. (www.max.com/chuck) announces that Chuck Norris and his wife Gena Norris will serve as media campaign spokespersons and worldwide ambassadors for the company's health and sports nutraceutical products. (Photo: http://photos.prnewswire.com/prnh/20130521/FL13779-a)(Logo: http://photos.prnewswire.com/prnh/20130521/FL13779LOGO-b) Available in eight countries, MAX's patented nutrients and nutritional products were...

2013-05-15 23:32:02

Perfect Choice Trading Inc. is the preferred channel for TR Zell nutritional supplements. New York, NY (PRWEB) May 15, 2013 Sheep placenta treatments are synonymously a niche lifestyle – only afforded by rich and famous. These procedures exclusively took place in spas nestled somewhere in the Switzerland. The returns of these exclusive treatments, one gets to look rejuvenated and more youthful. All were set to change when Dr. Paul Niehans discovered cell therapy. This effective...

2013-05-07 16:28:18

Penn State College of Medicine researchers state that oral supplementation can increase the body's stores of the powerful antioxidant, Glutathione. NEW YORK, May 7, 2013 /PRNewswire-iReach/ -- Glutathione is the body's master antioxidant involved in protecting cells and tissues from oxidants and a large variety of other toxins and insults. Debate over whether orally administered glutathione could be effective at enhancing glutathione levels in cells and tissues has simmered for...

2013-04-25 16:30:33

NASHVILLE, Tenn., April 25, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release its first quarter 2013 results after the market closes on Thursday, May 2, 2013. A conference call and live Internet webcast will be held on Thursday, May 2, 2013, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the...

2013-03-28 08:29:16

MOUNTAIN VIEW, Calif., March 28, 2013 /PRNewswire/ -- Edison Pharmaceuticals today announced that it has entered into a research/development and commercialization agreement with Dainippon Sumitomo Pharma Co., Ltd. (DSP) for the development of EPI-743 and EPI-589 in Japan. Under the terms of the agreement, DSP will gain development and commercialization rights in Japan in exchange for Edison receiving $35 million in upfront and $15 million in R&D support. In addition, Edison will...

2013-03-13 15:27:30

Gamma-aminobutyric acid (GABA) deficits have been implicated in schizophrenia and depression. In schizophrenia, deficits have been particularly well-described for a subtype of GABA neuron, the parvalbumin fast-spiking interneurons. The activity of these neurons is critical for proper cognitive and emotional functioning. It now appears that parvalbumin neurons are particularly vulnerable to oxidative stress, a factor that may emerge commonly in development, particularly in the context of...

2013-03-12 04:21:15

LOS ANGELES, March 12, 2013 /PRNewswire/ -- Veteran poker pro and 2006 CBC Intercontinental Poker Champion Yosh Nakano hosted a launch party for RealHangoverRelief.com to benefit the One Step Closer Foundation (http://www.1scf.com), a cerebral palsy charity. The party took place Feb. 21 at the Vintage Bar, adjacent to the L.A. hot spot Belasco Nightclub. In attendance were fellow poker veterans Marsha Waggoner, Robert Turner, Jon Mosero and Mort Silas, who at 90 plays poker six days...

2013-02-19 00:21:28

MOUNTAIN VIEW, Calif., Feb. 19, 2013 /PRNewswire/ -- Edison Pharmaceuticals today announced the initiation of a phase 2 clinical trial entitled, "Double-Blind, Placebo-Controlled Clinical Trial of EPI-743 in Patients with Cobalamin C Defect." The trial is a placebo-controlled study lasting 12 months, preceded by a six-month run-in phase for all patients to establish a defined clinical and metabolic baseline. The primary endpoint is improvement in visual function with secondary...

2013-02-14 16:25:15

NASHVILLE, Tenn., Feb. 14, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release 2012 year-end financial results after the market closes on Thursday, February 28, 2013. A conference call and live Internet webcast will be held on Thursday, February 28, 2013, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A...

2013-01-18 12:22:32

TAMPA, Fla., Jan. 18, 2013 /PRNewswire-iReach/ -- One of the most popular and powerful products offered by US Vitamin Injections is the anti-oxidant glutathione. Glutathione is an anti-oxidant that is contained within our bodies and acts as a buffer for any harmful toxins, chemicals or damaged cells that are introduced. Luckily the body is capable of producing its own glutathione which keeps the body healthy and functioning properly. (Photo:...